Variations in survival from breast cancer in Europe by age and country, 1978-1989

M. J. Quinn, C. Martinez-Garcia, F. Berrino

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

The objective of this study, part of the wider EUROCARE II collaborative project, was to examine variations by age and country in the relative survival of women from breast cancer in Europe, based on data for 145 000 cases in 1985-1989 and trends based on (245 000) cases for 1978-1989. Data were supplied by 42 cancer registries in 17 countries to a common protocol. Results for some countries where the participating registries covered only small proportions of the total population may not be representative of the whole country. In 1985-1989 there were wide differences among the 17 countries: survival was above the European average in Iceland, Finland, Sweden, Switzerland, France and Italy; around average in Denmark, The Netherlands, Germany and Spain; below average in Scotland, England and Slovenia; and well below average in Slovakia, Poland and Estonia. In France, Spain and Italy, but not in the U.K., there were wide differences in survival among the participating registries. Survival generally declined with age, particularly in the elderly (75 years and over) - this was most marked in Denmark, Scotland and England. Over the period 1978-1989, 1-year survival improved by 2% overall and 5-year survival by 6%. There were improvements in 5-year survival in all countries except Iceland, Germany, Switzerland and Estonia, and in all age groups except the youngest (15-44 years). It is likely that differences in the access to and quality of care in the various countries played a large part in explaining the differences in survival.

Original languageEnglish
Pages (from-to)2204-2211
Number of pages8
JournalEuropean Journal of Cancer
Volume34
Issue number14
DOIs
Publication statusPublished - Dec 1998

Fingerprint

Breast Neoplasms
Survival
Estonia
Registries
Iceland
Scotland
Denmark
Switzerland
England
Spain
Italy
France
Germany
Slovenia
Slovakia
Quality of Health Care
Poland
Finland
Sweden
Netherlands

Keywords

  • Age
  • Breast cancer
  • Europe
  • Survival
  • Trends

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Variations in survival from breast cancer in Europe by age and country, 1978-1989. / Quinn, M. J.; Martinez-Garcia, C.; Berrino, F.

In: European Journal of Cancer, Vol. 34, No. 14, 12.1998, p. 2204-2211.

Research output: Contribution to journalArticle

Quinn, M. J. ; Martinez-Garcia, C. ; Berrino, F. / Variations in survival from breast cancer in Europe by age and country, 1978-1989. In: European Journal of Cancer. 1998 ; Vol. 34, No. 14. pp. 2204-2211.
@article{00b8a1c7211e4566ad5f5e5092139a88,
title = "Variations in survival from breast cancer in Europe by age and country, 1978-1989",
abstract = "The objective of this study, part of the wider EUROCARE II collaborative project, was to examine variations by age and country in the relative survival of women from breast cancer in Europe, based on data for 145 000 cases in 1985-1989 and trends based on (245 000) cases for 1978-1989. Data were supplied by 42 cancer registries in 17 countries to a common protocol. Results for some countries where the participating registries covered only small proportions of the total population may not be representative of the whole country. In 1985-1989 there were wide differences among the 17 countries: survival was above the European average in Iceland, Finland, Sweden, Switzerland, France and Italy; around average in Denmark, The Netherlands, Germany and Spain; below average in Scotland, England and Slovenia; and well below average in Slovakia, Poland and Estonia. In France, Spain and Italy, but not in the U.K., there were wide differences in survival among the participating registries. Survival generally declined with age, particularly in the elderly (75 years and over) - this was most marked in Denmark, Scotland and England. Over the period 1978-1989, 1-year survival improved by 2{\%} overall and 5-year survival by 6{\%}. There were improvements in 5-year survival in all countries except Iceland, Germany, Switzerland and Estonia, and in all age groups except the youngest (15-44 years). It is likely that differences in the access to and quality of care in the various countries played a large part in explaining the differences in survival.",
keywords = "Age, Breast cancer, Europe, Survival, Trends",
author = "Quinn, {M. J.} and C. Martinez-Garcia and F. Berrino",
year = "1998",
month = "12",
doi = "10.1016/S0959-8049(98)00323-2",
language = "English",
volume = "34",
pages = "2204--2211",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "14",

}

TY - JOUR

T1 - Variations in survival from breast cancer in Europe by age and country, 1978-1989

AU - Quinn, M. J.

AU - Martinez-Garcia, C.

AU - Berrino, F.

PY - 1998/12

Y1 - 1998/12

N2 - The objective of this study, part of the wider EUROCARE II collaborative project, was to examine variations by age and country in the relative survival of women from breast cancer in Europe, based on data for 145 000 cases in 1985-1989 and trends based on (245 000) cases for 1978-1989. Data were supplied by 42 cancer registries in 17 countries to a common protocol. Results for some countries where the participating registries covered only small proportions of the total population may not be representative of the whole country. In 1985-1989 there were wide differences among the 17 countries: survival was above the European average in Iceland, Finland, Sweden, Switzerland, France and Italy; around average in Denmark, The Netherlands, Germany and Spain; below average in Scotland, England and Slovenia; and well below average in Slovakia, Poland and Estonia. In France, Spain and Italy, but not in the U.K., there were wide differences in survival among the participating registries. Survival generally declined with age, particularly in the elderly (75 years and over) - this was most marked in Denmark, Scotland and England. Over the period 1978-1989, 1-year survival improved by 2% overall and 5-year survival by 6%. There were improvements in 5-year survival in all countries except Iceland, Germany, Switzerland and Estonia, and in all age groups except the youngest (15-44 years). It is likely that differences in the access to and quality of care in the various countries played a large part in explaining the differences in survival.

AB - The objective of this study, part of the wider EUROCARE II collaborative project, was to examine variations by age and country in the relative survival of women from breast cancer in Europe, based on data for 145 000 cases in 1985-1989 and trends based on (245 000) cases for 1978-1989. Data were supplied by 42 cancer registries in 17 countries to a common protocol. Results for some countries where the participating registries covered only small proportions of the total population may not be representative of the whole country. In 1985-1989 there were wide differences among the 17 countries: survival was above the European average in Iceland, Finland, Sweden, Switzerland, France and Italy; around average in Denmark, The Netherlands, Germany and Spain; below average in Scotland, England and Slovenia; and well below average in Slovakia, Poland and Estonia. In France, Spain and Italy, but not in the U.K., there were wide differences in survival among the participating registries. Survival generally declined with age, particularly in the elderly (75 years and over) - this was most marked in Denmark, Scotland and England. Over the period 1978-1989, 1-year survival improved by 2% overall and 5-year survival by 6%. There were improvements in 5-year survival in all countries except Iceland, Germany, Switzerland and Estonia, and in all age groups except the youngest (15-44 years). It is likely that differences in the access to and quality of care in the various countries played a large part in explaining the differences in survival.

KW - Age

KW - Breast cancer

KW - Europe

KW - Survival

KW - Trends

UR - http://www.scopus.com/inward/record.url?scp=0032412976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032412976&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(98)00323-2

DO - 10.1016/S0959-8049(98)00323-2

M3 - Article

C2 - 10070288

AN - SCOPUS:0032412976

VL - 34

SP - 2204

EP - 2211

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 14

ER -